Researchers created a Modified Staging System for Waldenström macroglobulinemia that could improve risk stratification for treatment-naïve patients. Outcomes for Waldenström macroglobulinemia (WM) are often disparate, but newer therapies have...
Oncology / Hematology
RELEVANT ARTICLES IN Oncology / Hematology
CA-125 and PET/CT in Idiopathic Inflammatory Myopathy Cancer Diagnosis
CA-125 and PET/CT in Idiopathic Inflammatory Myopathy Cancer Diagnosis
The following is a summary of “Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies,” published in the September 2024 issue of Rheumatology by Wang et al. Researchers conducted a retrospective study to assess the effectiveness of...
Psychological Illness, CVD Risk Increased for Relatives, Spouses of Cancer Patients
Psychological Illness, CVD Risk Increased for Relatives, Spouses of Cancer Patients
MONDAY, Sept. 9, 2024 (HealthDay News) -- Cancer diagnosis is associated with an increased risk for psychological illness and cardiovascular disease among first-degree relatives and spouses of patients, according to a study published online Sept. 9 in Cancer.Using...
Advertisement
Most Patients With Stage I PDAC Are Upstaged on Histopathology
Most Patients With Stage I PDAC Are Upstaged on Histopathology
MONDAY, Sept. 9, 2024 (HealthDay News) -- More than 70 percent of patients with stage I pancreatic ductal adenocarcinoma (PDAC) and close to 30 percent with stage II PDAC are upstaged on histopathology, according to a research letter published online Sept. 5 in the...
Patient Education Needed to Successfully Integrate PROs Into EHRs
Patient Education Needed to Successfully Integrate PROs Into EHRs
Patients found high value in integrating patient-reported outcomes into electronic health records, but expressed several areas of confusion.
Haploidentical, Related, Unrelated: Does Donor Type Impact HTC Outcomes?
Haploidentical, Related, Unrelated: Does Donor Type Impact HTC Outcomes?
Matched sibling donors aside, donor type was not associated with significant differences in overall survival in patients with myelofibrosis who underwent HCT.
CA-125 and PET/CT in Idiopathic Inflammatory Myopathy Cancer Diagnosis
CA-125 and PET/CT in Idiopathic Inflammatory Myopathy Cancer Diagnosis
The following is a summary of “Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies,” published in the September 2024 issue of Rheumatology by Wang et al. Researchers conducted a retrospective study to assess the effectiveness of...
Psychological Illness, CVD Risk Increased for Relatives, Spouses of Cancer Patients
Psychological Illness, CVD Risk Increased for Relatives, Spouses of Cancer Patients
MONDAY, Sept. 9, 2024 (HealthDay News) -- Cancer diagnosis is associated with an increased risk for psychological illness and cardiovascular disease among first-degree relatives and spouses of patients, according to a study published online Sept. 9 in Cancer.Using...
Most Patients With Stage I PDAC Are Upstaged on Histopathology
Most Patients With Stage I PDAC Are Upstaged on Histopathology
MONDAY, Sept. 9, 2024 (HealthDay News) -- More than 70 percent of patients with stage I pancreatic ductal adenocarcinoma (PDAC) and close to 30 percent with stage II PDAC are upstaged on histopathology, according to a research letter published online Sept. 5 in the...
Patient Education Needed to Successfully Integrate PROs Into EHRs
Patient Education Needed to Successfully Integrate PROs Into EHRs
Patients found high value in integrating patient-reported outcomes into electronic health records, but expressed several areas of confusion.
Haploidentical, Related, Unrelated: Does Donor Type Impact HTC Outcomes?
Haploidentical, Related, Unrelated: Does Donor Type Impact HTC Outcomes?
Matched sibling donors aside, donor type was not associated with significant differences in overall survival in patients with myelofibrosis who underwent HCT.
Advertisement
Advertisement
Stop Physician Burnout: the Hidden Danger of AI Note Writing Software
Stop Physician Burnout: the Hidden Danger of AI Note Writing Software
AI note writing software offers physicians short-term stress relief, but physician stress may shift to employer demand for increased patient quotas.
Medications in Obesity Treatment: Types, Benefits, and Considerations
Medications in Obesity Treatment: Types, Benefits, and Considerations
Dr. Jill Bryson explains which medications can be beneficial when incorporated into an obesity treatment plan, and factors that determine medication use.
Drawing the Line When “Curbsiding”
Drawing the Line When “Curbsiding”
Dr. MedLaw discusses where the line between safely offering informal consultation, or "curbsiding," and taking on the liability of a consultation gets drawn.
CME / CE
Lifestyle Intervention Linked With Higher PCR In Women On Neoadjuvant Chemo
This course discusses how primary care clinicians instruct their patients about the benefits of follow-up after receiving abnormal results after a cancer screening.
PODCAST
Biomarker Testing and NSCLC, Part 1
Sep 04, 2024
The Influence of Nutrition on Sleep Patterns
Aug 21, 2024Advertisement
MORE STORIES IN Oncology / Hematology
FILTER ARTICLES BY:
Advertisement
PODCAST
Biomarker Testing and NSCLC, Part 1
Sep 04, 2024The Influence of Nutrition on Sleep Patterns
Aug 21, 2024CARTOONS
Elbowing In
Elbowing In
Medical cartoon in which man needs an elbow specialist, but meets Joint Chief of Staff.
Big Pill to Swallow
Big Pill to Swallow
Medical cartoon in which the pharmacist is giving the customer a prescription bottle containing one huge, once-a-year pill.
You Gonna Finish That?
You Gonna Finish That?
Medical cartoon by Jonny Hawkins about patient asking another patient about finishing IV bag.
BUSINESS OF MEDICINE
Drawing the Line When “Curbsiding”
Drawing the Line When “Curbsiding”
Dr. MedLaw discusses where the line between safely offering informal consultation, or "curbsiding," and taking on the liability of a consultation gets drawn.
How Cash-Based Healthcare May Benefit Both Patients and Physicians
How Cash-Based Healthcare May Benefit Both Patients and Physicians
Cash-based healthcare aims to provide all individuals with vital healthcare services, eliminating the burden of navigating insurance company requirements.
What the Re-Classification of Cannabis as a Schedule III Drug Means for Physicians
What the Re-Classification of Cannabis as a Schedule III Drug Means for Physicians
Physicians should educate themselves on the benefits of medical marijuana, recognizing that cannabis may soon be re-classified as a Schedule III drug.
ADVERTISEMENT
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.